Related references
Note: Only part of the references are listed.Effects of Surgery on Survival of Early-Stage Patients With SCLC: Propensity Score Analysis and Nomogram Construction in SEER Database
Yuyan Wang et al.
FRONTIERS IN ONCOLOGY (2020)
Association of Breast Cancer Surgery With Quality of Life and Psychosocial Well-being in Young Breast Cancer Survivors
Shoshana M. Rosenberg et al.
JAMA SURGERY (2020)
Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
A. Bardia et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Advances in Targeted Therapies for Triple-Negative Breast Cancer
Kelly E. McCann et al.
DRUGS (2019)
Patient-reported outcomes in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer receiving olaparib versus chemotherapy in the OlympiAD trial
Mark Robson et al.
EUROPEAN JOURNAL OF CANCER (2019)
Advances in the systemic treatment of triple-negative breast cancer
J. M. Lebert et al.
CURRENT ONCOLOGY (2018)
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Jennifer K. Litton et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
How shall we treat early triple-negative breast cancer (TNBC): from the current standard to upcoming immuno-molecular strategies
Ji Hyun Park et al.
ESMO OPEN (2018)
Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
Xiaoxian Li et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Sung-Bae Kim et al.
LANCET ONCOLOGY (2017)
Oncoplastic Breast-Conserving Surgery for Tumors Larger than 2 Centimeters: Is it Oncologically Safe? A Matched-Cohort Analysis
Francesca De Lorenzi et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
Jingdan Qiu et al.
JOURNAL OF CANCER (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Triple-Negative Breast Cancer Is Not a Contraindication for Breast Conservation
Farrell C. Adkins et al.
ANNALS OF SURGICAL ONCOLOGY (2011)
Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
Ana M. Gonzalez-Angulo et al.
CLINICAL CANCER RESEARCH (2011)
Increased Risk of Locoregional Recurrence for Women With T1-2N0 Triple-Negative Breast Cancer Treated With Modified Radical Mastectomy Without Adjuvant Radiation Therapy Compared With Breast-Conserving Therapy
Bassam S. Abdulkarim et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients
David S. P. Tan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Descriptive analysis of estrogen receptor (ER)negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype - A population-based study from the California Cancer Registry
Katrina R. Bauer et al.
CANCER (2007)
Multi-institutional validation of a new renal cancer-specific survival nomogram
Pierre I. Karakiewicz et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Tumour size as a predictor of axillary node metastases in patients with breast cancer
Sharon Laura et al.
ANZ JOURNAL OF SURGERY (2006)
Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer
Bernard H. Bochner et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Re: Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
J Palacios et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Share Paper
